| Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis GP Aithal, JA Thomas, PV Kaye, A Lawson, SD Ryder, I Spendlove, ... Gastroenterology 135 (4), 1176-1184, 2008 | 867 | 2008 |
| Immunosurveillance is active in colorectal cancer as downregulation but not complete loss of MHC class I expression correlates with a poor prognosis NFS Watson, JM Ramage, Z Madjd, I Spendlove, IO Ellis, JH Scholefield, ... International journal of cancer 118 (1), 6-10, 2006 | 313 | 2006 |
| αB crystallin expression in nonlenticular tissues and selective presence in ubiquitinated inclusion bodies in human disease J Lowe, H McDermott, I Pike, I Spendlove, M Landon, RJ Mayer The Journal of pathology 166 (1), 61-68, 1992 | 239 | 1992 |
| Expression of the stress‐related MHC class I chain‐related protein MICA is an indicator of good prognosis in colorectal cancer patients NFS Watson, I Spendlove, Z Madjd, R McGilvray, AR Green, IO Ellis, ... International journal of cancer 118 (6), 1445-1452, 2006 | 205 | 2006 |
| Total loss of MHC class I is an independent indicator of good prognosis in breast cancer Z Madjd, I Spendlove, SE Pinder, IO Ellis, LG Durrant International journal of cancer 117 (2), 248-255, 2005 | 179 | 2005 |
| Vascular endothelial growth factor expression in ovarian cancer: a model for targeted use of novel therapies? TJ Duncan, A Al-Attar, P Rolland, IV Scott, S Deen, DTY Liu, I Spendlove, ... Clinical Cancer Research 14 (10), 3030-3035, 2008 | 148 | 2008 |
| CD55 is over-expressed in the tumour environment L Li, I Spendlove, J Morgan, LG Durrant British journal of cancer 84 (1), 80-86, 2001 | 141 | 2001 |
| Ballooned neurons in several neurodegenerative diseases and stroke contain αB crystallin J Lowe, DR Errington, G Lennox, I Pike, I Spendlove, M Landon, ... Neuropathology and applied neurobiology 18 (4), 341-350, 1992 | 133 | 1992 |
| The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer A Popple, LG Durrant, I Spendlove, P Rolland, IV Scott, S Deen, ... British journal of cancer 106 (7), 1306-1313, 2012 | 132 | 2012 |
| Enhanced expression of the complement regulatory protein CD55 predicts a poor prognosis in colorectal cancer patients LG Durrant, MA Chapman, DJ Buckley, I Spendlove, RA Robins, ... Cancer Immunology, Immunotherapy 52, 638-642, 2003 | 128 | 2003 |
| High expression of Lewisy/bantigens is associated with decreased survival in lymph node negative breast carcinomas Z Madjd, T Parsons, NFS Watson, I Spendlove, I Ellis, LG Durrant Breast Cancer Research 7, 1-8, 2005 | 125 | 2005 |
| The ubiquitin-binding protein p62 is expressed in breast cancers showing features of aggressive disease P Rolland, Z Madjd, L Durrant, IO Ellis, R Layfield, I Spendlove Endocrine-related cancer 14 (1), 73-80, 2007 | 123 | 2007 |
| Dementia with β-amyloid deposition: involvement of αB-crystallin supports two main diseases J Lowe, M Landon, I Pike, I Spendlove, H Mcdermott, RJ Mayer The Lancet 336 (8713), 515-516, 1990 | 122 | 1990 |
| Costimulation via CD55 on human CD4+ T cells mediated by CD97 M Capasso, LG Durrant, M Stacey, S Gordon, J Ramage, I Spendlove The Journal of Immunology 177 (2), 1070-1077, 2006 | 113 | 2006 |
| Production and characterization of a polyclonal antibody to the c‐erbB‐3 protein: Examination of c‐erbB‐3 protein expression in adenocarcinomas DN Poller, I Spendlove, C Baker, R Church, IO Ellis, GD Plowman, ... The Journal of pathology 168 (3), 275-280, 1992 | 100 | 1992 |
| Upregulation of MICA on high-grade invasive operable breast carcinoma Z Madjd, I Spendlove, R Moss, S Bevin, SE Pinder, NFS Watson, I Ellis, ... Cancer immunity 7 (1), 2007 | 98 | 2007 |
| Expression of the membrane complement regulatory protein CD59 (protectin) is associated with reduced survival in colorectal cancer patients NFS Watson, LG Durrant, Z Madjd, IO Ellis, JH Scholefield, I Spendlove Cancer Immunology, Immunotherapy 55, 973-980, 2006 | 91 | 2006 |
| Immunology in the clinic review series; focus on cancer: glycolipids as targets for tumour immunotherapy LG Durrant, P Noble, I Spendlove Clinical and experimental immunology 167 (2), 206, 2012 | 85 | 2012 |
| Complement decay accelerating factor (DAF)/CD55 in cancer I Spendlove, JM Ramage, R Bradley, C Harris, LG Durrant Cancer immunology, immunotherapy 55, 987-995, 2006 | 85 | 2006 |
| Structural and functional characterization of a novel T cell receptor co-regulatory protein complex, CD97-CD55 RJM Abbott, I Spendlove, P Roversi, H Fitzgibbon, V Knott, P Teriete, ... Journal of Biological Chemistry 282 (30), 22023-22032, 2007 | 80 | 2007 |
